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Sex-based differences in human susceptibility to cardiac ventricular tachyarrhythmias likely
result from the emergent effects of multiple intersecting processes that fundamentally
differ in male and female hearts. Included are measured differences in the genes encoding
key cardiac ion channels and effects of sex steroid hormones to acutely modify electri-
cal activity. At the genome-scale, human females have recently been shown to have lower
expression of genes encoding key cardiac repolarizing potassium currents and connexin43,
the primary ventricular gap-junction subunit. Human males and females also have distinct
sex steroid hormones. Here, we developed mathematical models for male and female
ventricular human heart cells by incorporating experimentally determined genomic differ-
ences and effects of sex steroid hormones into the O’Hara–Rudy model.These “male” and
“female” model cells and tissues then were used to predict how various sex-based differ-
ences underlie arrhythmia risk. Genomic-based differences in ion channel expression were
alone sufficient to determine longer female cardiac action potential durations (APD) in both
epicardial and endocardial cells compared to males. Subsequent addition of sex steroid
hormones exacerbated these differences, as testosterone further shortened APDs, while
estrogen and progesterone application resulted in disparate effects on APDs. Our results
indicate that incorporation of experimentally determined genomic differences from human
hearts in conjunction with sex steroid hormones are consistent with clinically observed
differences in QT interval, T -wave shape and morphology, and critically, in the higher vul-
nerability of adult human females to Torsades de Pointes type arrhythmias. The model
suggests that female susceptibility to alternans stems from longer female action poten-
tials, while reentrant arrhythmia derives largely from sex-based differences in conduction
play an important role in arrhythmia vulnerability.
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INTRODUCTION
Female sex is a determinant of susceptibility to inherited and
acquired long-QT syndrome and associated with Torsade de
Pointes (TdP) arrhythmias (Pham and Rosen, 2002; Nakagawa
et al., 2005; Furukawa and Kurokawa, 2007; James et al., 2007;
Lowe et al., 2012). Studies have shown both genomic differences
in ion channel expression in males versus females and sex-specific
acute effects of sex steroid hormones that modulate ion chan-
nels (Bai et al., 2005; Nakagawa et al., 2005; Verkerk et al., 2005;
Xiao et al., 2006; Furukawa and Kurokawa, 2007; Sims et al., 2008;
Yang et al., 2012). Recent clinical and experimental studies suggest
that differences in vulnerability to some arrhythmias may arise
directly from these fundamental sex-based differences in cardiac
tissue (Di Diego et al., 2002; Fish and Antzelevitch, 2003; Gaborit
et al., 2010; Nattel et al., 2010). However, teasing out the key deter-
minants of sex-based differences in arrhythmia vulnerability is an
exceedingly complex problem since it is difficult to reveal how spe-
cific components (i.e., acute effects of hormones versus genomic
effects underlying variable ion channel expression) contribute to
differences in electrophysiological substrate and vulnerability to
arrhythmia.
Recent work from the Demolombe lab has provided the
first comprehensive glimpse into sex-based differences in car-
diac ion channel composition and distribution in non-diseased
human hearts (Gaborit et al., 2010; Nattel et al., 2010). A high-
throughput quantitative approach revealed genome-scale differ-
ences in expression of key genes encoding cardiac ion channels and
transporters subunits in human epicardial and endocardial male
and female tissues. Of note were sex-based differences in expres-
sion of genes encoding channels that determine conduction and
repolarization. Female hearts had reduced expression of the K(+)-
channel subunits HERG, minK, Kir2.3, Kv1.4, KChIP2, SUR2,
and Kir6.2, and lower expression of connexin43 and phospho-
lamban compared to males. Experiments demonstrated concur-
rence of changes between gene and protein-expression for HERG,
minK, Kv1.4, KChIP2, IRX5, Nav1.5, and connexin43. The findings
reported in this study suggest a potential vulnerability of females
to repolarization abnormalities, but did not show the functional
effects of genomic-based differences to determine is they were
sufficient for observed clinical differences in males and females.
Although females are at increased risk for inherited and
acquired long-QT syndrome and TdP compared to males, risk and
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QT interval fluctuations have been shown to change with phases
of the menstrual cycle in some studies, suggesting a role for fluc-
tuating hormones (Furukawa and Kurokawa, 2007; James et al.,
2007). During the menstrual follicular phase (prior to ovulation),
QT interval is longer than in the luteal phase (following ovulation)
when progesterone is increased (Nakamura et al., 2007). Moreover,
susceptibility to drug-induced arrhythmias is exaggerated in the
late follicular phase where estrogen is highest (James et al., 2007).
Arrhythmic events associated with acquired and inherited LQTs
are reduced during phases where progesterone is high (Janse de
Jonge et al., 2001; Nakagawa et al., 2006).
Recent studies have shown that progesterone and estrogen
affect cardiac electrophysiology in an acute manner via effects on
ion channels (James et al., 2007). Progesterone results in enhance-
ment of the slow delayed rectifier K+ current (IKs) and rapid
shortening of Action potential duration (APD; Nakamura et al.,
2007). The effects of progesterone are mediated by nitric oxide
(NO) released via non-genomic activation of endothelial NO syn-
thase (eNOS; Furukawa and Kurokawa, 2007). Estrogen, on the
other hand, primarily affects the rapidly activating component
of the delayed rectifier K+ current, IKr via direct binding to the
channel and reducing current (Kakusaka et al., 2009).
In males, testosterone increases during puberty, a phase during
which a reduction in QT intervals and arrhythmia susceptibility
is observed compared to females (Bidoggia et al., 2000). The QT
interval then gradually increases with age, apparently correspond-
ing to age related reduction in serum testosterone (Bidoggia et al.,
2000). Men are much less likely to develop TdP arrhythmias in the
presence of congenital or drug-induced prolongation of QT inter-
val (Pham et al., 2002; El-Eraky and Thomas, 2003; James et al.,
2007). Experiments in female animals have demonstrated that
administration of testosterone reduces pro-arrhythmia induced by
dofetilide (Pham et al., 2002). The action of testosterone, like prog-
esterone, is mediated via eNos production of NO and modification
of channel kinetics (Bai et al., 2005).
In order to begin to understand the contributions of various
components that contribute to sex-based differences in arrhyth-
mia risk, we utilized experimental data describing the differences
in male and female expression of ion channel gene transcripts to
build male and female human cardiac cell models via modifica-
tion of the O’Hara–Rudy human ventricular cell model. Acute
effects of physiologically relevant human concentrations of sex
steroid hormones testosterone, progesterone, and estrogen were
then applied. The male model incorporated measured effects of
two concentrations of testosterone (adolescence and senescence)
on the critical plateau currents IKs and L-type Ca2+ current (ICaL).
The female model included effects of physiological concentra-
tions (at different points in the menstrual cycle) of progesterone
on IKs and estrogen on IKr. Simulations revealed the conditions
(i.e., pacing, drugs) required for sustained reentrant arrhythmias.
The model simulations allowed us to explore the complex non-
linear interplay between processes on disparate time scales (acute
and genomic effects of hormones) that contribute to sex-based
arrhythmias.
To realize the most basic biological mechanisms underlying
sex-based differences in male and female hearts and their influ-
ence on arrhythmia proclivity is the first necessary step that must
be taken to ultimately lead to development of specific diagnosis
criteria and distinct therapeutic targeting of cardiac disease in
males and females. Basic understanding of mechanisms is required
to envision a future when women will have designated sex-based
parameter regimes and not be classified as “atypical” because they
fall outside of the “normal” range designated for male physiology
and pathology.
MATERIALS AND METHODS
CELLULAR SIMULATIONS
The model formulation for the baseline male endocardial cell was
the O’Hara–Rudy endocardial model cell (O’Hara et al., 2011).
Experimentally measured differences in mRNA expression were
expressed relative to male endocardial cells (male endocardial is
always“1”). The computational models for male epicardial, female
epicardial, and female endocardial cells were derived by alter-
ing channel conductances based on measurements in these cell
types relative to the published O’Hara–Rudy endocardial model
cell. Unless otherwise indicated, simulated action potentials (APs)
were recorded at the 1000th paced beat (BCL= 1000 ms) in single
endocardial and epicardial cells using the index (calculated from
the average experimentally obtained value) as indicated in Table
S1 in Supplementary Material. The numerical method used for
updating the voltage was forward Euler. Source code is available
upon request. Full detailed Methods accompany this paper in the
Supplementary Material.
RESULTS
EFFECTS OF SEX-BASED DIFFERENCES IN HUMAN ION CHANNEL
EXPRESSION ON ACTION POTENTIALS
In a recent study from the Demolombe group (Gaborit et al.,
2010), a high-throughput quantitative approach was used to deter-
mine the expression level of key cardiac ion channel genes in
epicardial and endocardial ventricular tissue from non-diseased
explanted male and female human hearts. This study revealed crit-
ical differences in male and female expression of ion channel gene
transcripts that were validated by and consistent with resultant
protein-expression for all of the subunits that were examined. We
utilized these data (shown in Table S1 in the detailed Methods
in the Supplementary Material) in construction of “male” and
“female” human heart cell computational models by scaling the
conductances of the corresponding currents in the O’Hara–Rudy
human ventricular cell model as described in the accompanying
detailed Methods in the Supplementary Material. The baseline
O’Hara–Rudy model formulation was assumed to be the “average
male” endocardial cell, while male epicardial and female endo-
cardial and epicardial conductances were scaled relative to this
baseline. Because much variability exists within the experimen-
tal data for each channel transcript, we constructed 5000 distinct
models with combinations of ionic conductances based on a ran-
dom value chosen from within the standard deviation of the
experimental data. Regardless of the parameter sets that were used
in the models, a clear prediction emerged from the model sim-
ulations as shown in Figure 1: consistent with the observation
that females have longer QT intervals than males, “female” cell
reconstructions had longer APD than “male” cell reconstructions
for both endocardial and epicardial cell types. In column A of
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FIGURE 1 | Channel conductances chosen randomly from within
the standard deviation of experimental data (Table S1 the Methods
in Supplementary Material) for 5000 simulations of human
ventricular cell.The 1000th paced beat at a cycle length of 1000 ms is
shown in endocardial and epicardial cell types. Action potentials (APs)
from male and female models are shown (A). The distributions of APD
variations (B) and the distributions of maximum upstroke velocity (C) for
each model are shown. The average values are indicated. The index
values derived from the mean experimental values are indicated by the
red bars.
Figure 1, the 1000th paced beat at a cycle length of 1000 ms is
shown for seven combinations of ion channel conductance para-
meters picked at random within the standard deviation of the
data in male and female endocardial and epicardial cell types as
indicated. APDs and maximum upstroke velocities (dvm/dtmax)
compiled from 5000 distinct cases (again with combinations of ion
channel conductance parameters picked at random from within
the standard deviation of the data) in male and female models
are shown columns B and C, respectively. The “index” values
indicated by the red vertical lines, were generated by using the
mean experimental data values for each component in scaling the
ion channel conductances in the model. That the cellular level
parameters, APD and upstroke velocity, derived from the average
ionic conductance parameter values were within the middle of the
distribution for all cell types indicates that these are reasonable
representations of an “average” cell in each class. This analysis also
serves as a test of sensitivity of the model behaviors to the under-
lying parameters, which indicated clear sex- and cell-type-based
trends for all parameter combinations, providing confidence in
the model predictions. The “index” models for male and female
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endocardial and epicardial cells were used for the remainder of
simulations in this study.
SIMULATED GENOMIC-BASED DIFFERENCES IN COMBINATION WITH
HORMONE EFFECTS ON ACTION POTENTIALS IN SINGLE CELLS
We next utilized the“index”APs (indicated by red lines in Figure 1)
and added additional acute effects of sex steroid hormones in the
model to predict the combined effects of genomic-based differ-
ences in expression of key cardiac channels with human physio-
logical concentrations of sex hormones on human APD. In recent
studies, progesterone enhanced IKs (Nakamura et al., 2007), while
testosterone primarily increased IKs and inhibited ICa,L (Bai et al.,
2005). Application of estradiol significantly suppressed IKr current
(Kurokawa et al., 2008). Based on the experimentally observed
effects of physiological concentrations of sex steroid hormones
on these channels, we modified the kinetics and conductance
of model ion currents (described in Methods of Supplementary
Material).
Upon acute application of two physiological concentrations of
testosterone (dihydrotestosterone DHT) 10 and 35 nM shown in
Figure 2A (left), reflecting normal low and high ranges in post-
pubescent pre-senescent males (Dorgan et al., 2002), the model
simulations predict APD shortening in endocardial cells compared
to no hormone (NH, 264 ms) by 3.0% (256 ms) and 5.3% (250 ms)
at 10 and 35 nM testosterone, respectively. The model predictions
also suggest modest APD shortening in epicardial cells (Figure S1A
in Supplementary Material) with testosterone compared to NH
(249 ms) by 2.8% (242 ms) and 4.0% (239 ms) at 10 and 35 nM
testosterone, respectively.
Figure 2A (right panel) shows the combined effects of female
channel gene expression and the hormones 17β-estradiol (E2)
and progesterone during the early follicular, late follicular, and
luteal phases of the menstrual cycle. During the early follicular
stage, E2= 0.1 nM, progesterone= 2.5 nM, during the late follic-
ular stage, E2= 1.0 nM, progesterone= 2.5 nM, and during the
luteal phase, E2= 0.7 nM, progesterone= 40.6 nM (Janse de Jonge
et al., 2001). As see in Figure 2A right panel, the simulations pre-
dict the longest APD in the late follicular phase in endocardial cells
(335 ms), considerably longer than in the early follicular (312 ms –
6.9% reduction) or luteal phase (322 ms – 3.9% reduction). This
trend was consistent for model epicardial cells (Figure S1B in Sup-
plementary Material), where late follicular phase (313 ms), was
longer than early (290 ms – 7.4% reduction) and luteal phase
(301 ms – 3.8% reduction).
Due to the predicted sex-based differences in APD, we pos-
tulated that APD restitution, a quantity describing adaptation of
APD to the preceding diastolic interval (DI), and the propensity
of the cell to develop arrhythmogenic rhythms such as alter-
nans (alternating long-short pattern of APD) would be different
between the sexes. To examine the sex-based rate-dependence of
cellular dynamics, cells were paced at constant frequency as indi-
cated for 1000 beats (see Methods in Supplementary Material) for
male and female cells with hormone combinations as shown. As
shown in Figure 2B, the virtual male cell with 10 nM testosterone
(red) has indistinguishable dynamics compared to NH (blue), but
required substantially faster pacing to develop alternans in the
presence of 35 nM (green) testosterone [faster than 292 beats per
FIGURE 2 | Simulated action potentials duration (APD) and APD
alternans. (A) APD for the 1000th paced beat at a cycle length of 1000 ms
in single endocardial cells. APDs with no hormone (NH; Table S1 the
Methods in Supplementary Material) and two physiological concentrations
of DHT (10 and 35 nM) in male cells are shown in left. Estradiol and
progesterone at different physiological concentrations corresponding to
three stages of the menstrual cycle were added in female cells (right). (B)
Male epicardial cells with DHT treatment developed alternans at fast pacing
rates, between cycle lengths 180 and 210 ms. (C) In female epicardial cells
alternans developed at a much slower basic cycle length during the late
follicular phase (pink) compared to luteal (green) and early follicular (red). IKr
block increased susceptibility to alternans development in male (black in B)
and dramatically in female models (black in C).
minute (BPM)], indicating that testosterone is protective. When
the IKr blocker E-4031 (10 nM) was administered (black) to simu-
late the common situation of promiscuous hERG block, there was
a right shift of the restitution curve, indicating the development
of alternans at slower, more physiologically attainable, albeit very
high, frequencies (onset of alternans at 267 BPM).
In female model cells (Figure 2C), alternans developed at con-
siderably slower frequencies, with similar onset for NH compared
to the early follicular phase, with a marked right shift of the curve
observed for the luteal phase (green) and the late follicular phase
(pink). IKr block (E-4031 10 nM) dramatically increased suscep-
tibility to alternans (at 197 BPM) in the female simulations as
indicated by the right shift of the black curve. These results indi-
cate that the female cells in the presence of IKr block, particularly
in the late follicular phase of the menstrual cycle when estradiol is
highest, are considerably more vulnerable to the arrhythmogenic
alternans rhythm. Restitution slopes are shown in Figure S2 in
Supplementary Material.
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SIMULATION OF TISSUE-LEVEL EFFECTS OF GENOMIC DIFFERENCES
AND HORMONES
We next computed the effects of sex-based genomic differences
alone in a one-dimensional transmural strand of coupled cells
comprising epicardial to endocardial regions (detailed explanation
of construction of the tissue is in the Methods in Supplementary
Material) to determine the sex-based genomic effects in an elec-
tronically coupled male (A) and female tissue (B; Figure 3). We
also computed spatial gradients of depolarization and repolariza-
tion to generate an electrogram to allow us to compare “ECG”
parameters between male (blue) and female (red) virtual tissues
(Figure 3C).
Action potentials were initiated via a stimulus applied to the
first endocardial cell that propagated to the last epicardial cell
along the 360 cell tissue. The T -wave in Figure 3C for both male
and females is inverted and poorly pronounced indicating that
the endocardial cells fired first and repolarized first, even though
endocardial cells have a longer intrinsic APD in isolation. The
flat T -wave indicates that electronic coupling in the tissue is suf-
ficiently strong to damp large repolarization differences between
epicardial and endocardial cells so that there is very little dispersion
of repolarization. Importantly, the simulation also shows a prolon-
gation of repolarization in the female compared to male, consistent
with the longstanding observations that females have longer QT
intervals than males (Jose and Collison, 1970; Huikuri et al., 1996;
Burke et al., 1997; Stramba-Badiale et al., 1997; Bidoggia et al.,
2000; Smetana et al., 2002). Sex-based differences in conduction
velocity are shown in Figures S3 and S4 in Supplementary Material.
In Figures 3D,E, we used the transmural tissue model to simu-
late effects of low and high physiological concentration of testos-
terone on APD in simulated transmural one-dimensional tissue.
The model predicts that testosterone-induced faster repolariza-
tion and consequent QT interval reduction (3D) to 315 ms (0.94%
shortening – 10 nM DHT) and 310 ms (2.5% shortening – 35 nM
DHT) compared to NH (318 ms) in male tissue in Figure 3A.
Clinical studies have suggested that the QT intervals fluctu-
ate during the menstrual cycle, suggesting that progesterone may
reverse effects of the estradiol-induced QT prolongation (Naka-
gawa et al., 2006). Figures 3F–I represents the results of simula-
tions in a 1D cable at combined hormone concentrations observed
during various phases of the menstrual cycle. Simulations show a
QT interval that is longest (375 ms) in the late follicular phase (3G)
compared to 365 ms in the luteal phase and 355 ms in the early
follicular phases, in agreement with the clinically observed QT
shortening (≈10 ms shortening in the luteal phase compared to the
follicular phase; Nakagawa et al., 2006). The models demonstrate
that despite the presence of estradiol (0.7 nM) during the luteal
phase, high progesterone (40.6 nM) results in luteal phase short-
ening of APD and a QT interval (on the pseudo ECG) reduction
of 2.7% (from the late follicular phase).
FIGURE 3 | Sex-based differences in human cardiac ion channels
altered myocyte electrophysiology in transmural 1-dimensional tissue
models. Simulated action potentials (APs) at 1000 ms pacing frequency in
a 3.6 cm cardiac fiber. Time is shown on the x -axis and voltage on the
z -axis. The 500th paced beats are shown. (A) Simulated male fibers with
no hormone. (B) Female fibers with no hormone. (C) Pseudo ECGs show
the genomic effects on QT intervals for male [(A) – blue] and female
[(B) – red] models. (D–H) Simulated combined effects of estradiol and
progesterone during the menstrual cycle and DHT on APs. (I)The virtual
ECGs (the 500th beat) show QT intervals change during the menstrual
cycle and two physiological concentrations of DHT, indicated by black
arrows. (J,K) Disparate responses to IKr channel block in the late follicular
phase versus with DHT. (L)The computed ECG (the 500th beat) shows
that QT interval is substantially longer in the late follicular phase [(K) – red)
than with DHT [(J) – black]. Ninety five percentage repolarization of last
cells indicated red arrows.
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COMBINED EFFECTS OF HORMONES AND I KR CHANNEL BLOCKING
DRUGS
Clinical and experimental studies have shown that females are
especially susceptible to QT interval prolongation by IKr block-
ing drugs (Kurokawa et al., 2008). This finding may partially
explain why females are more prone to drug-induced arrhythmias
(Makkar et al., 1993; Lehmann et al., 1996). Hence, we next tested
the combined effects of hormone and the IKr channel blocker
E-4031 on drug-induced QT interval prolongation. Experiments
(Kurokawa et al., 2008) have previously shown that physiologically
relevant application of estradiol increased hERG block by E-4031,
whereas testosterone did not. Figures 3J–L illustrates a simulation
in one-dimensional transmural tissue of coupled cells (360 cells)
in the presence of 35 nM testosterone during E-4031 treatment
compared to combined female hormones during the late follicular
phase where estradiol is highest. With 10 nM E-4031, the simu-
lated tissue-level pseudo ECG QT (panel L) is markedly shorter
with testosterone application (black line; 325 ms) compared to the
QT interval in the presence of female hormones (420 ms). These
results are consistent with clinical observations that females expe-
rience more QT interval prolongation than males in the presence
of IKr blocking drugs (Benton et al., 2000; El-Eraky and Thomas,
2003; Kurokawa et al., 2008).
In Figure 4, we show that the model predicts the develop-
ment of complex rhythms including alternans,“Wenckebach-like”
rhythms and conduction block in transmural tissue composed of
a one-dimensional strand of coupled cells during rapid pacing
(see Materials and Methods for pacing protocol). Tissues com-
posed of male cells required fast pacing frequencies to develop
these rhythms in the presence of testosterone (Figure 4A, upper
panel) and even simulated addition of the IKr blocker E-4031 did
not overwhelm testosterone’s protective effect (Figure 4A, lower
panel). Male tissues develop (Figure 4A) alternans around 205 and
200 BPM with drug addition. Consistent with the simulations in
single cells showing steeper APD restitution in females (Figure S2
in Supplementary Material), female transmural tissue developed
conduction block at considerably slower pacing rate compared to
the male case. Female tissue during the late follicular phase gen-
erated alternans and Wenckebach phenomena at physiologically
relevant frequencies of 173 BPM and 157 BPM with IKr blocker,
where conduction block was also observed.
EFFECTS OF SEX-BASED GENOMIC DIFFERENCES, HORMONES AND I KR
BLOCK ON PROPENSITY TO REENTRANT EXCITATION IN TISSUES
Critically timed stimuli can initiate self-sustaining spiral waves
(Mines, 1914; Allessie et al., 1973) capable of degeneration into
fibrillatory rhythms leading to sudden cardiac death. Thus, we
sought to systematically determine the likelihood of arrhythmia
induced by irregular spontaneous stimuli in tissue models of the
human male and female heterogeneous ventricular myocardium.
We tested vulnerability to persistent reentry induced by ectopic
stimuli with physiologically relevant concentrations of sex steroid
hormones in the presence and absence of the common clinical
situation of IKr block by simulating a heterogeneous cardiac tis-
sue containing an endocardial region (tissue columns 1–160) and
an epicardial region (tissue columns 161–360) based on record-
ings from human tissue (Glukhov et al., 2010; Lou et al., 2011)
FIGURE 4 | Alternans occurs at slow pacing rates in female tissue.
Transmural tissue composed of epi-/endocardial ventricular cells were paced
at various cycle lengths. (A) Male with DHT 35 nM and/or E-4031 10 nM. (B)
Female in late follicular phase (top) and with E-4031 10 nM (bottom).
as described in detail in the Methods in Supplementary Mate-
rial. We also incorporated anisotropic effects by setting Dx and
Dy such that the ratio of conduction velocity is 1:2 (Frank and
Kranias, 2000). APD dispersion maps are shown in Figures S5
(male) and Figure S6 (female) in Supplementary Material. Fol-
lowing pacing for 50 beats (s1) at BCL= 1000 ms along the entire
endocardial length, a premature stimulus (S2) was then applied
in a 2.7 cm× 1.5 cm area on the top edge of the endocardial
region within the vulnerable window (described in Methods in
Supplementary Material).
Figure 5 shows voltage snapshots in time as indicated following
the application of the simulated ectopic beat via application of the
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FIGURE 5 | Attempted induction of reentry in male
heterogeneous tissue without (A) or with (B,C) DHT 10 or 35nM
in the presence of 10nM E-4031 (D).Tissues (5.4 cm×6.6 cm) were
stimulated along left edge (endocardium) and propagated across the
tissue followed by a premature stimulus applied in the endocardial
region (see Materials and Methods). Six snapshots following
application of DHT and/or drug at indicated time points. Voltages are
indicated by the color gradient.
premature stimulus S2 for four male cases. In the absence of hor-
mones or drugs (A), an initiated wave propagates in a reentrant
manner and makes only one turn (first row). In B, the same behav-
ior is shown following testosterone (10 nM) application alone.
With application of 35 nM DHT, the reentrant wave fails to make
a complete turn (C), and application of the IKr blocker E-4031
(D), does not substantially worsen the situation – only one turn of
the reentrant wave is observed.
The outcome was starkly different in the female (Figure 6). In
Figure 6A (top), the simulations suggest that in the absence of
female sex steroid hormones, a single reentrant wave occurs and
then extinguishes during the second reentrant cycle. A nearly iden-
tical pattern was observed during the early follicular phases (B).
However, the late follicular phase (C) and the luteal phase (D) are
apparently more vulnerable to reentrant activity – in these cases,
the self-sustaining oscillations persist for more than 2 and 1.6 s,
respectively. When E-4031 was applied during the late follicular
phase (E), a premature stimulus resulted in the robust induction
and persistence of a spiral wave. Sustained reentry was introduced
in this condition that persisted indefinitely, suggesting female vul-
nerability to reentry is especially marked during the late follicular
phase of the menstrual cycle. The early follicular and luteal phase
with E-4031 results are shown in Figure S7 in Supplementary
Material.
Because the experimental data (Nakamura et al., 2007) also
showed that progesterone inhibited ICa,L with cAMP treatment, we
next investigated how the effects of progesterone on ICa,L influence
the reentrant behaviors. Figures 7A–C show that the reentry wave
persists for about 1.81 s in the late follicular phases, was longer than
in the early follicular and luteal phases (0.8 s). Figure 7E suggests
that during late follicular phase with E-4031 application, a persis-
tence of spiral wave was observed. However, the reentrant waves
terminated around 1.25 s in both early follicular (Figure 7D) and
luteal phases with IKr blocker (Figure 7F), suggesting protective
effects of progesterone during cAMP-stimulations. The model also
predicts the under SNS stimulation, progesterone-inducted APD
reductions in single cell during the luteal phase shown in Figure
S8 in Supplementary Material.
In order to isolate the mechanism of female susceptibility to
reentrant arrhythmia, we made some targeted swaps of model
components. As seen in Figure 8A, we first added female hor-
mones (1 nM E2 and 2.5 nM progesterone) and the IKr blocker
E-4031 to the “genetic” male model and tested for vulnerabil-
ity to reentry using the S1–S2 protocol already described. The
addition of drug and female hormones had the expected effect
to increase the APD. But the faster male conduction velocity
resulted in a rapid collision of the wave front with the wave
tail after a single rotation. Similar behavior was observed when
the genetic female model with female hormones corresponding
to the late follicular phase was combined with the IKr blocker
E-4031, but male connexin 43 level was the only swapped compo-
nent (Figure 8B). Again, this simulation suggests that sex-based
differences in conduction play an important role in arrhythmia
vulnerability.
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FIGURE 6 | Attempted induction of reentry in female heterogeneous tissues in the absence (A) or presence of female hormones (B–D) and I Kr block
during late follicular phase (E). Seven snapshots following application of hormones and/or drug at indicated time points. The protocol was as in Figure 5.
DISCUSSION
The first observation of sex-based electrophysiological differences
on the ECG came from Bazett approximately 85 years ago (Bazett,
1920). Bazett (1920) noted that women had significantly longer
QT intervals than men, despite having higher resting heart rates.
Many studies have since confirmed Bazett’s observations of sex-
based differences in the ECG (Jose and Collison, 1970; Rautaharju
et al., 1992; Huikuri et al., 1996; Burke et al., 1997; Stramba-Badiale
et al., 1997; Bidoggia et al., 2000; Smetana et al., 2002). It is thus sur-
prising that even the most basic scientific investigations to reveal
how sex-based biological differences influence cardiovascular-
linked disease outcomes are just beginning to be undertaken. For
example, investigations into how male and female hearts differ
fundamentally in terms of gene expression and how sex steroid
hormones modify heart function and cardiovascular risk are still
in early stages. It is critical that such studies be undertaken and
expanded now. It will be essential to effectively disseminate infor-
mation and manage risk, diagnosis, treatment and follow-up for
males and females with cardiovascular rhythm disorders. But, the
sex-based mechanisms that underlie disease disparity in women
and men must be determined before these effective prevention and
treatment strategies can be effectively deployed.
Several studies have suggested that sex hormones affect cardiac
repolarization by regulating gene expression and causing func-
tional physiological changes in the heart, as well as through rapid
acute effects on cardiac ion channels. In this study, we sought to
use a computationally based approach to explore the complex non-
linear interplay between genomic differences and acute fluctuating
effects of hormones that contribute to sex-based differences in
arrhythmias.
We validated our model predictions against surrogate markers
of arrhythmia risk (e.g., prolongation of the QT interval in females
versus males). Clinical studies have shown that females have longer
corrected QT interval than males (420 versus 400 ms; Stramba-
Badiale et al., 1997; Ebert et al., 1998; Nakagawa et al., 2005). Our
simulations suggest that genetic differences in expression of key
cardiac ion channels can explain sex-based differences in APD.
Addition of sex steroid hormones exacerbated these differences,
Frontiers in Physiology | Computational Physiology and Medicine September 2012 | Volume 3 | Article 360 | 8
Yang and Clancy Sex-based arrhythmias
FIGURE 7 | During SNS stimulations simulated reentry wave on female heterogeneous tissues in the presence of female hormones (A–C) and I Kr
blocker (D–F).Time pointes and menstrual cycle phases are indicated. The protocol was as in Figure 5.
especially when comparing high physiologically realistic concen-
trations of the male hormone testosterone (35 nM) to the late
follicular phase during the menstrual cycle when estradiol is high-
est and progesterone is low. Our model simulations predicted
that increased APD in the female made the development of alter-
nans and other arrhythmia-linked complex rhythms, including
Wenckebach periodicity and conduction block, arise at slower,
physiologically achievable heart rates, which may put females at
particular risk.
We also sought to determine if sex-based differences in expres-
sion of key cardiac ion channel proteins and physiologically rel-
evant concentrations of sex steroid hormones would exacerbate
or protect against persistent self-sustaining reentrant arrhythmias,
a clinically significant precedent event to lethal arrhythmias that
have been observed with significantly higher incidence in women
in the setting of acquired long-QT (Regitz-Zagrosek, 2006). We
found that following application of a premature stimulus in the
presence of female hormones during the late follicular phase with
the IKr blocker E-4031 induced sustained reentry in the trans-
mural tissue model. In addition, connexin43 play a key factor for
sustained reentry. Connexin43 was reduced in females compared
to males (Gaborit et al., 2010). Our study suggests that this sex-
based difference is a key factor in female vulnerability of reentrant
arrhythmia.
We previously undertook a study of sex-based differences in
electrical properties of cells in response to acute hormone appli-
cation in a guinea pig cardiac cell model. In the guinea pig
computational cells, simulations predicted the protective effects
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FIGURE 8 | Attempted induction of reentry in male heterogeneous
tissues with female hormones and I Kr block during the late follicular
phase (A) and female heterogeneous tissues in the late follicular phase
and E-4031 10nM with measured male connexin 43 level (B). Four
snapshots following application of hormones and/or drug at indicated time
points. The protocol was as in Figure 5.
of progesterone against drug-induced arrhythmias. However, con-
trary to the results of simulations in the guinea pig model, the
human model predictions suggest that progesterone alone is not
sufficient to reduce risk of TdP arrhythmias in females. This
species disparity is explained by variability in K+ current expres-
sion, especially IKs, which is notably less prominent in humans
(Virag et al., 2001; Grandi et al., 2010; O’Hara et al., 2011). The
human model simulations suggest that progesterone is protective
against estradiol-induced LQT syndrome only when concurrent
sympathetic stimulation is present. This is because progesterone
mitigates the increase in ICa,L that occurs via PKA phosphorylation
subsequent to adrenergic activation.
LIMITATIONS
It is important to note that β-adrenergic stimulation has also been
shown to modify testosterone effects on ICa,L current. A limita-
tion of this study is that we were not able to directly simulate
these effects because the experimental data under physiological
testosterone concentrations were not available. Even so, effects
of sympathetic stimulation are expected to add to the protective
effects of testosterone by further reducing ICa,L current in response
to β-adrenergic activation leading to further reduction in APD and
reduced potential for sustained reentrant activity. We were also
unable to independently determine properties of a baseline male
cell, and so began this study with the assumption that the O’Hara–
Rudy model represents a baseline male model. The original model
was based on majority male data (56%), but a substantial fraction
was female (44%). We acknowledge this assumption as a limi-
tation of the study, which may have led to an underestimate of
male and female differences in electrophysiology and arrhythmia
vulnerability.
Another limitation of this study is that we used mRNA expres-
sion data as a surrogate for actual electrophysiological record-
ings of ionic currents because such recordings are not yet avail-
able. Although most of the key changes to electrophysiological
components included in our models were the subject of experi-
ments that indeed demonstrated concurrence of changes between
gene and protein-expression for HERG, minK, Kv1.4, KChIP2,
IRX5, Nav1.5, and connexin43, we acknowledge that these data
are less definitive than electrophysiological recordings.
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SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at http://www.frontiersin.org/Computational_Physiology_and_
Medicine/10.3389/fphys.2012.00360/abstract
Table S1 | Sex-based differences in ion channel subunit expression from
non-diseased ventricles1. Ratios are relative to the male endocardial cell.
Table S2 | Effects of estradiol on I Kr.
Table S3 | Effects of testosterone on I Ks and I Ca,L.
Table S4 | Effects of progesterone on I Ks and I Ca,L.
Table S5 | Conduction velocity.
Table S6 | QT intervals comparison.
Figure S1 | Simulated action potentials (APs) for the 1000th paced beat at
a cycle length of 1000ms in single epicardial cells. Action potential durations
(APDs) with no hormone (HM) addition are calculated using the index value
(also shown in Figure 1B – red bars) from Table S1 (see Methods). (A) Effects of
two physiological concentrations of male hormone (DHT – 10 and 35 nM) in
male cells. (B) Estrogen and progesterone at different physiological
concentrations corresponding to three stages of the menstrual cycle were
added in female cells: early follicular phase (estrogen: 0.1 nM and progesterone:
2.5 nM), late follicular phase (estrogen: 1 nM and progesterone: 2.5 nM) and
luteal phase (estrogen: 0.7 nM and progesterone: 40.6 nM). The APD for each
case is indicated.
Figure S2 | Modeling genomic and acute hormone effects on electrical
restitution in single cells. (A) APD restitution curves generated with S1–S2
pacing protocol is shown. (B) Slope of APD restitutions. Gender, cell types, and
concentrations of sex steroid hormone are indicated.
Figure S3 | Calculated 5000 cases of conduction velocity using the index
ratio of gap-junction for each model (see Methods).The ratio of ion channel
conductance was randomly chosen within one standard deviation of
experimental data (Table S1).
Figure S4 | 5000 cases of conduction velocity were simulated within a
standard deviation of experimental data (Table S1) in male and female
models. Ion channel conductance was fixed at the index values. The results of
using the index ratio of gap-junction are shown in red bars.
Figure S5 |Two-dimensional transmural tissues from male model in the
absence or presence of DHT or with drug addition show linear reductions
in APDs from endocardium to epicardium. APDs are indicated by color
gradient.
Figure S6 | Simulated transmural linear APD gradients in female model
through the menstrual cycles (early follicular, late follicular, and luteal) and
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during late follicular phase with drug application. APDs are indicated by
color gradient.
Figure S7 | Simulated reentry wave on female heterogeneous tissues
(Figure S6) in the presence of female hormones (B–D) and I Kr block during
early follicular (A) and luteal phases (B). Seven snapshots following
application of hormones and/or drug at indicated time points. The same protocol
as in Figure 4 was used.
Figure S8 | Simulated APs under SNS stimulations for the 1000th paced
beat at a cycle length of 1000ms in single endocardial and epicardial cell.
Estrogen and progesterone at different physiological concentrations
corresponding to three stages of the menstrual cycle were added in female
cells: early follicular phase (estrogen: 0.1 nM and progesterone: 2.5 nM), late
follicular phase (estrogen: 1 nM and progesterone: 2.5 nM) and luteal phase
(estrogen: 0.7 nM and progesterone: 40.6 nM). The APD for each case is
indicated.
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